metastatic prostate cancer

A recent phase 3 clinical trial has revealed a promising method that may significantly enhance how doctors predict survival rates and tailor treatments for men with advanced prostate cancer.

By analyzing circulating tumor cells (CTCs) in the blood, researchers have … Continue Reading